TY - JOUR
T1 - Essential prerequisites for successful bioprocess development of biological CH4 production from CO2 and H2
AU - Rittmann, Simon Karl-Maria Rasso
AU - Seifert, Arne
AU - Herwig, Christoph
N1 - Publisher Copyright:
© 2015 Informa Healthcare USA, Inc.
PY - 2015
Y1 - 2015
N2 - The production and storage of energy from renewable resources steadily increases in importance. One opportunity is to utilize carbon dioxide (CO2)-type hydrogenotrophic methanogens, which are an intriguing group of microorganisms from the domain Archaea, for conversion of hydrogen and CO2 to methane (CH4). This review summarizes the current state of the art of bioprocess development for biological CH4 production (BMP) from pure cultures with pure gasses. The prerequisites for successful quantification of BMP by using closed batch, as well as fed-batch and chemostat culture cultivation, are presented. This review shows that BMP is currently a much underexplored field of bioprocess development, which mainly focuses on the application of continuously stirred tank reactors. However, some promising alternatives, such as membrane reactors have already been adapted for BMP. Moreover, industrial-based scale-up of BMP to pilot scale and larger has not been conducted. Most crucial parameters have been found to be those, which influence gas-limitation fundamentals, or parameters that contribute to the complex effects that arise during medium development for scale-up of BMP bioprocesses, highly stressing the importance of holistic BMP quantification by the application of well-defined physiological parameters. The much underexplored number of different genera, which is mainly limited to Methanothermobacter spp., offers the possibility of additional scientific and bioprocess development endeavors for the investigation of BMP. This indicates the large potential for future bioprocess development considering the possible application of bioprocessing technological aspects for renewable energy storage and power generation.
AB - The production and storage of energy from renewable resources steadily increases in importance. One opportunity is to utilize carbon dioxide (CO2)-type hydrogenotrophic methanogens, which are an intriguing group of microorganisms from the domain Archaea, for conversion of hydrogen and CO2 to methane (CH4). This review summarizes the current state of the art of bioprocess development for biological CH4 production (BMP) from pure cultures with pure gasses. The prerequisites for successful quantification of BMP by using closed batch, as well as fed-batch and chemostat culture cultivation, are presented. This review shows that BMP is currently a much underexplored field of bioprocess development, which mainly focuses on the application of continuously stirred tank reactors. However, some promising alternatives, such as membrane reactors have already been adapted for BMP. Moreover, industrial-based scale-up of BMP to pilot scale and larger has not been conducted. Most crucial parameters have been found to be those, which influence gas-limitation fundamentals, or parameters that contribute to the complex effects that arise during medium development for scale-up of BMP bioprocesses, highly stressing the importance of holistic BMP quantification by the application of well-defined physiological parameters. The much underexplored number of different genera, which is mainly limited to Methanothermobacter spp., offers the possibility of additional scientific and bioprocess development endeavors for the investigation of BMP. This indicates the large potential for future bioprocess development considering the possible application of bioprocessing technological aspects for renewable energy storage and power generation.
KW - Biomethane
KW - Bioreactor design
KW - Media demands
KW - Methanogens
KW - Physiological parameters
KW - Power to gas
KW - Quantification
KW - Scale-up
UR - http://www.scopus.com/inward/record.url?scp=84932174762&partnerID=8YFLogxK
U2 - 10.3109/07388551.2013.820685
DO - 10.3109/07388551.2013.820685
M3 - Article
SN - 1549-7801
VL - 35
SP - 141
EP - 151
JO - Critical Reviews in Biotechnology
JF - Critical Reviews in Biotechnology
IS - 2
ER -